{
    "clinical_study": {
        "@rank": "62079", 
        "acronym": "POMPE 2013", 
        "arm_group": {
            "arm_group_label": "Pompe patients", 
            "description": "Adult onset pompe patients being or not treated with enzyme therapy replacement"
        }, 
        "biospec_descr": {
            "textblock": "Blood an urine samples will be obtained"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This project is an observational prospective study in which patients affected by an adult\n      onset Pompe disease will be followed-up during three years using different clinical,\n      analytical and radiological tests in order to know which is the natural history of the\n      disease and which is the impact that treatment with recombinant enzyme has in the\n      progression of the disease."
        }, 
        "brief_title": "A Natural History Study of Adult Onset Pompe Disease Using Muscle MRI", 
        "completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Pompe Disease", 
        "condition_browse": {
            "mesh_term": "Glycogen Storage Disease Type II"
        }, 
        "detailed_description": {
            "textblock": "Study aim:\n\n      The principal objective of the study is to find biomarkers that quantify the natural\n      progression of the disease and to know if they are useful to determine the improvement or\n      lack of impairment of the disease in response to Enzyme Replacement Therapy (ERT).\n\n      Study design:\n\n      A single center observational prospective study.\n\n      Patients:\n\n      Patients with adult onset POMPE disease (onset of symptoms after two years old) and\n      molecular diagnosis confirming the disease are eligible\n\n      Methods:\n\n      Clinical information will be obtained according to a pre-defined protocol including six\n      visits: screening visit, baseline, 6 month, 12 month, 24 month and 36 month.\n\n      In each visit we will perform the following tests: clinical assessment (including interview\n      with patients, quality of live questionnaires, timed tests and assessment of muscle balance\n      using a myometer), analytical tests (blood and urine tests), cardiac test (Electrocardiogram\n      (ECG) and cardiac echography), respiratory assessment (using spirometer) and skeletal muscle\n      imaging (Muscle MRI).\n\n      All data collect will be introduced in a database and afterwards statistically analyzed.\n\n      Expected results:\n\n      We expect to find a biomarker useful to follow-up the progression of Pompe disease. This\n      biomarker has to be sensitive to the changes that muscle function may have after treatment\n      with ERT.\n\n      Funding:\n\n      This project is funded by Genzyme, a Sanofi company"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pompe disease confirmed using genetic study\n\n          -  Onset of symptoms more than 2 years old\n\n          -  To be able to come to the hospital and follow all the visits\n\n          -  Patients with respiratory involvement are welcomed\n\n        Exclusion Criteria:\n\n          -  Patients unable to perform a MRI (respiratory problems can be solved using mechanical\n             ventilation)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "8 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult onset Pompe Patients"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914536", 
            "org_study_id": "IIBSP-POM-2013-46"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "POMPE", 
            "Glycogenosis type II", 
            "Acid maltase deficiency"
        ], 
        "lastchanged_date": "August 29, 2013", 
        "location": {
            "contact": {
                "email": "JDiazM@santpau.cat", 
                "last_name": "Jordi D\u00edaz Manera, MD PhD", 
                "phone": "0034-935565986", 
                "phone_ext": "5986"
            }, 
            "contact_backup": {
                "email": "SSegovia@santpau.cat", 
                "last_name": "Sonia Segovia Simon", 
                "phone": "0034-935565978", 
                "phone_ext": "5978"
            }, 
            "facility": {
                "address": {
                    "city": "Barcelona", 
                    "country": "Spain", 
                    "zip": "08025"
                }, 
                "name": "Hospital de la Santa Creu iSant Pau"
            }, 
            "investigator": [
                {
                    "last_name": "Jordi D\u00edaz-Manera, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Eduard Gallardo, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Aida Alejaldre, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Izaskun Belmonte", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Natural History Study of Adult Onset Pompe Disease Using Muscle MRI", 
        "overall_contact": {
            "email": "JDiazM@santpau.cat", 
            "last_name": "Jordi D\u00edaz_Manera, MD PhD", 
            "phone": "0034-935565986", 
            "phone_ext": "5986"
        }, 
        "overall_contact_backup": {
            "email": "SSegovia@santpau.cat", 
            "last_name": "Sonia Segovia Simon", 
            "phone": "0034-935565978", 
            "phone_ext": "5978"
        }, 
        "overall_official": [
            {
                "affiliation": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
                "last_name": "Jordi D\u00edaz Manera, MD PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
                "last_name": "Isabel Illa, MD pHD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To know the natural progression of the disease regarding muscle atrophy measured using muscle MRI during a period of three years.", 
            "measure": "Changes in muscle atrophy using muscle MRI in patients with adult onset Pompe disease", 
            "safety_issue": "No", 
            "time_frame": "baseline, 6 months, one year, two years and three years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914536"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To study progression of muscle weakness using manual and informatic devices as myometry. We will compare clinical progression with Muscle MRI results.", 
                "measure": "Muscle strength", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months, one year, two years and three years"
            }, 
            {
                "description": "We will obtain blood samples of all the patients to study the microRNA profile and different time points", 
                "measure": "Micro RNA study", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months, one year, two years and three years"
            }
        ], 
        "source": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
        "sponsors": {
            "collaborator": {
                "agency": "Genzyme, a Sanofi Company", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}